Clincosm LogoSign in Get a demo

metastatic urothelial carcinoma

Showing 26 - 43 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Urothelial Carcinoma, Metastatic Renal Cell Carcinoma Trial

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • +2 more
  • Isovue-M 200
  • Durham, North Carolina
    Duke University Medical Center
Apr 1, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +17 more
  • Cryosurgery
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 29, 2021

Urine Omics Predicting IO Therapy Responses in mUC Patients

Recruiting
  • Metastatic Urothelial Carcinoma
  • No intervention required
  • Taipei, Taiwan
    National Taiwan University Hospital
Dec 19, 2021

Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma Trial in China (MRG002)

Recruiting
  • Locally Advanced Urothelial Cancer
  • Metastatic Urothelial Carcinoma
  • Hefei, Anhui, China
  • +35 more
Dec 13, 2021

Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Boston (Pembrolizumab, Cryoablation)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Metastatic Urothelial Carcinoma Trial in Santa Monica (Pembrolizumab + sEphB4-HSA)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Pembrolizumab + sEphB4-HSA
  • Santa Monica, California
    Sarcoma Oncology Center
Sep 27, 2021

Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Recruiting
  • Bladder Cancer
  • +12 more
  • Raleigh, North Carolina
    xCures Virtual Site
Sep 20, 2021

Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma Trial in New York (Nivolumab, Atezolizumab, Radiation &

Terminated
Has Results
  • Metastatic Renal Cell Carcinoma
  • Metastatic Urothelial Carcinoma
  • New York, New York
    Weill Cornell Medicine - New York Presbyterian Hospital
Aug 26, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +38 more
  • Scottsdale, Arizona
  • +2 more
Aug 27, 2021

Metastatic Urothelial Carcinoma Trial in Houston (Laboratory Biomarker Analysis, Pemetrexed Disodium)

Terminated
Has Results
  • Metastatic Urothelial Carcinoma
  • Laboratory Biomarker Analysis
  • Pemetrexed Disodium
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2021

Metastatic Urothelial Carcinoma Trial in Milan (Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel)

Completed
  • Metastatic Urothelial Carcinoma
  • Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel
  • Milan, Italy
  • +1 more
May 12, 2021

Metastatic Urothelial Carcinoma Trial in Ramat Gan (Tumor Infiltrating Lymphocytes (TIL), Proleukin)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Ramat Gan, Israel
    Sheba Medical Center
Feb 8, 2021

Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Worldwide (Rucaparib)

Terminated
Has Results
  • Bladder Cancer
  • +7 more
  • Scottsdale, Arizona
  • +63 more
Oct 16, 2020